Netherlands· NL-298ea056107b
Nuvaxovid, dispersie voor injectie
A other viral vaccines product containing recombinant spike proteïne zonder signaal peptide van het sars-cov-2 virus, registered in Netherlands by Sanofi Winthrop Industrie. The same ATC class is registered in 6 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Recombinant spike proteïne zonder signaal peptide van het sars-cov-2 virus is registered in 6 of 19 countries.
Countries holding a registration under ATC J07BX (other viral vaccines), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 3 of them publish a price we can compare per daily dose
Recombinant spike proteïne zonder signaal peptide van het sars-cov-2 virus · ATC J07BX
6 / 19 countries
- Denmark
- Icelandprice
- Ireland
- Netherlands
- Polandprice
- Switzerlandprice
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- RECOMBINANT SPIKE PROTEÏNE ZONDER SIGNAAL PEPTIDE VAN HET SARS-COV-2 VIRUS
- Manufacturer
- Sanofi Winthrop Industrie
- Country
- Netherlands (NL)
- ATC code
- J07BX
- ATC class
- Other viral vaccines
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_idEU/1/21/1618
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under J07BX
Other viral vaccines, as other registers publish it.
- SwitzerlandAbrysvo, Pulver und Lösungsmittel zur Herstellung einer InjektionslösungPfizer AG
- SwitzerlandAbrysvo, Pulver und Lösungsmittel zur Herstellung einer InjektionslösungPfizer AG
- PolandImvanexBavarian Nordic A/S
- IcelandIMVANEXBavarian Nordic A/S
- IrelandIMVANEX suspension for injectionBavarian Nordic A/S
- IcelandIxchiqValneva Austria GmbH
- IrelandIXCHIQ powder and solvent for solution for injection Chikungunya vaccine (live)Valneva Austria GmbH
- DenmarkmRESVIAModerna Biotech Spain S.L.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ea9f7955-2cad-48a3-ae2f-51e4260b4fc2 GET /v1/drugs/ea9f7955-2cad-48a3-ae2f-51e4260b4fc2?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Dispersie voor injectie",
"route": "Intramusculair gebruik",
"soort": null,
"source": "cbg_meb",
"smpc_url": "https://www.ema.europa.eu/en/documents/product-information/nuvaxovid-epar-product-information_nl.pdf",
"strength": null,
"atc_label": "Other Viral Vaccines",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp127964",
"excipients": [
"CHOLESTEROL",
"DINATRIUMWATERSTOFFOSFAAT 7-WATER (E 339)",
"FOSFATIDYLCHOLINE, EI",
"KALIUMCHLORIDE (E 508)",
"NATRIUMCHLORIDE",
"NATRIUMDIWATERSTOFFOSFAAT 1-WATER (E 339)",
"NATRIUMHYDROXIDE (E 524)",
"POLYSORBAAT 80 (E 433)",
"QUILLAJA SAPONARIA MOLINA SCHORS, GEZUIVERD EXTRACT, FRACTIE A",
"QUILLAJA SAPONARIA MOLINA SCHORS, GEZUIVERD EXTRACT, FRACTIE C",
"WATER VOOR INJECTIE",
"ZOUTZUUR (E 507)"
],
"substances": [
"RECOMBINANT SPIKE PROTEÏNE ZONDER SIGNAAL PEPTIDE VAN HET SARS-COV-2 VIRUS"
],
"leaflet_url": null,
"authorised_at": "2021/12/20",
"procedure_number": "EMEA/H/C/005808",
"dispensing_status": "Uitsluitend recept",
"registration_number": "EU/1/21/1618",
"additional_monitoring": "Y"
}See everything about recombinant spike proteïne zonder signaal peptide van het sars-cov-2 virus.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.